First-line immunotherapy for patients with advanced stage or metastatic non-small cell lung cancer…finally what threshold of PD-L1 expression on tumor cells?
Transl Lung Cancer Res
.
2019 Oct;8(5):728-730.
doi: 10.21037/tlcr.2019.04.18.
Author
Paul Hofman
1
2
3
Affiliations
1
Université Côte d'Azur, CHU Nice, FHU OncoAge, Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Nice, France.
2
Université Côte d'Azur, CNRS, INSERM, IRCAN, FHU OncoAge, Nice, France.
3
Université Côte d'Azur, CHU Nice, FHU OncoAge, Hospital-Integrated Biobank (BB-0033-00025), Nice, France.
PMID:
31737511
PMCID:
PMC6835100
DOI:
10.21037/tlcr.2019.04.18
No abstract available
Publication types
Editorial
Comment